Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance

Seminars in Cell and Developmental Biology

Volumn 12, Issue 3, 2001, Pages 247-256

  Hrycyna, Christine A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

ABC superfamily; Chemotherapy; Multidrug resistance; Mutational analysis; P glycoprotein

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; GLYCOPROTEIN P; MEMBRANE PROTEIN; NUCLEOTIDE BINDING PROTEIN;

BINDING SITE; CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; DRUG BINDING SITE; GENE EXPRESSION SYSTEM; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; MAMMAL; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

MAMMALIA;

EID: 0035783809     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.2000.0250     Document Type: Article

References (97)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398
2. Gottesman MM, Pastan I (1988) The multidrug-transporter: A double-edged sword. J Biol Chem 263:12163-12166
3. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427
4. Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I (1995) Genetic analysis of the multidrug transporter. Annu Rev Genet 29:607-649
5. Higgins CF, Hiles ID, Whalley K, Jamieson DJ (1985) Nucleotide binding by membrane components of bacterial periplasmic binding protein-dependent transport systems. EMBO J 4:1033-1039
6. Higgins CF et al. (1986) A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 323:448-450
7. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654
8. Miyake K et al. (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 59:8-13
9. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells [published erratum appears in Proc Natl Acad Sci USA 1999 Mar 2;96(5):2569]. Proc Natl Acad Sci USA 95:15665-15670
10. Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res 58:5337-5339
11. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486-4490
12. Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for the human 'MDR1' (P-glycoprotein) gene confers multidrug resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004-3008
13. Gros P, Ben Neriah Y, Croop J, Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728-731
14. Guild BC, Mulligan RC, Gros P, Housman DE (1988) Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc Natl Acad Sci USA 85:1595-1599
15. Goldstein LJ et al. (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116-124
16. Schoenlein PV (1993) Molecular cytogenetics of multiple drug resistance. Cytotechnology 12:63-89
17. Schoenlein PV (1994) Role of gene amplification in drug resistance. Cancer Treat Res 73:167-200
18. Loo TW, Clarke DM (1995) Membrane topology of a cysteine-less mutant of human P-glycoprotein. J Biol Chem 270:843-848
19. Horio M, Gottesman MM, Pastan I (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85:3580-3584
20. Raviv Y, Pollard HB, Bruggemann EP, Pastan I, Gottes-man MM (1990) Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J Biol Chem 265:3975-3980
21. Higgins CF, Gottesman MM (1992) Is the multidrug transporter a flippase? Trends Biochem Sci 17:18-21
22. Walker JE, Saraste M, Runswick MJ, Gay NJ (1982) Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1:945-951
23. Ames GF (1986) Bacterial periplasmic transport systems: Structure, mechanism, and evolution. Annu Rev Biochem 55:397-425
24. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport. Nature 346:362-365
25. Loo TW, Clarke DM (1995) Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. J Biol Chem 270:21449-21452
26. Evans GL, Ni B, Hrycyna CA, Chen D, Ambudkar SV, Pastan I, Germann UA, Gottesman MM (1995) Heterologous expression systems for P-glycoprotein: E. coli, yeast, and baculovirus. J Bioenerg Biomembr 27:43-52
27. Lerner-Marmarosh N, Gimi K, Urbatsch IL, Gros P, Senior AE (1999) Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins. J Biol Chem 274:34711-34718
28. Ramachandra M, Ambudkar SV, Chen D, Hrycyna CA, Dey S, Gottesman MM, Pastan I (1998) Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry 37:5010-5019
29. Luckow VA (1993) Baculovirus systems for the expression of human gene products. Curr Opin Biotechnol 4:564-572
30. Miller LK (1993) Baculoviruses: High-level expression in insect cells. Curr Opin Genet Dev 3:97-101
31. Urbatsch IL, Julien M, Carrier I, Rousseau ME, Cayrol R, Gros P (2000) Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein. Biochemistry 39:14138-14149
32. Moss B (1991) Vaccinia virus: A tool for research and vaccine development. Science 252:1662-1667
33. Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA (1996) Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Mol Biol Cell 7:1485-1498
34. Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1998) Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system. Methods Enzymol 292:456-473
35. Ramachandra M, Gottesman MM, Pastan I (1998) Recombinant vaccinia virus vectors for functional expression of P-glycoprotein in mammalian cells. Methods Enzymol 292:441-455
36. Hamada H, Tsuruo T (1986) Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789
37. Mechetner EB, Roninson IB (1992) Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a mono-clonal antibody. Proc Natl Acad Sci USA 89:5824-5828
38. Germann UA, Pastan I, Gottesman MM (1993) P-glycoproteins: Mediators of multidrug resistance. Semin Cell Biol 4:63-76
39. Azzaria M, Schurr E, Gros P (1989) Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol Cell Biol 9:5289-5297
40. Muller M, Bakos E, Welker E, Varadi A, Germann UA, Gottes-man MM, Morse BS, Roninson IB, Sarkadi B (1996) Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. J Biol Chem 271:1877-1883
41. Urbatsch IL, Beaudet L, Carrier I, Gros P (1998) Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites. Biochemistry 37:4592-4602
42. Urbatsch IL, Sankaran B, Bhagat S, Senior AE (1995) Both P-glycoprotein nucleotide-binding sites are catalytically active. J Biol Chem 270:26956-26961
43. Urbatsch IL, Sankaran B, Weber J, Senior AE (1995) P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 270:19383-19390
44. Hrycyna CA, Ramachandra M, Ambudkar SV, Ko YH, Pedersen PL, Pastan I, Gottesman MM (1998) Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem 273:16631-16634
45. Senior AE, al-Shawi MK, Urbatsch IL (1995) The catalytic cycle of P-glycoprotein. FEBS Lett 377:285-289
46. Senior AE, Bhagat S (1998) P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites. Biochemistry 37:831-836
47. Senior AE, Gadsby DC (1997) ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. Semin Cancer Biol 8:143-150
48. Hrycyna CA, Ramachandra M, Germann UA, Cheng PW, Pastan I, Gottesman MM (1999) Both ATP sites of human P-glycoprotein are essential but not symmetric. Biochemistry 38:13887-13899
49. Julien M, Gros P (2000) Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity. Biochemistry 39:4559-4568
50. Sauna ZE, Ambudkar SV (2000) Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc Natl Acad Sci USA 97:2515-2520
51. Sauna ZE, Ambudkar SV (2001) Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein: The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J Biol Chem 276:11653-11661
52. Van Veen HW, Margolles A, Muller M, Higgins CF, Kon-ings WN (2000) The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J 19:2503-2514
53. Urbatsch IL, Gimi K, Wilke-Mounts S, Senior AE (2000) Conserved walker A Ser residues in the catalytic sites of P-glycoprotein are critical for catalysis and involved primarily at the transition state step. J Biol Chem 275:25031-25038
54. Urbatsch IL, Gimi K, Wilke-Mounts S, Senior AE (2000) Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein. Biochemistry 39:11921-11927
55. Bruggemann EP, Germann UA, Gottesman MM, Pastan I (1989) Two different regions of P-glycoprotein are photoaffinity labeled by azidopine. J Biol Chem 264:15483-15488
56. Bruggemann EP, Chaudhary V, Gottesman MM, Pastan I (1991) Pseudomonas exotoxin fusion proteins are potent im-munogens for raising antibodies against P-glycoprotein. Biotechniques 10:202-209
57. Bruggemann EP, Currier SJ, Gottesman MM, Pastan I (1992) Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J Biol Chem 267:21020-21026
58. Greenberger LM (1993) Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-Glycoprotein are within, or immediately C-Terminal to, transmembrane domain-6 and domain-12. J Biol Chem 268:11417-11425
59. Morris DI, Greenberger LM, Bruggemann EP, Cardarelli CO, Gottesman MM, Pastan I, Seamon KB (1994) Localization of the forskolin labeling sites to both halves of P-glycoprotein: Similarity of the sites labeled by forskolin and prazosin. Mol Pharmacol 46:329-337
60. Loo TW, Clarke DM (1997) Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. J Biol Chem 272:31945-31948
61. Loo TW, Clarke DM (2000) Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane. J Biol Chem 275:39272-39278
62. Loo TW, Clarke DM (1999) Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane. J Biol Chem 274:35388-35392
63. Liu R, Siemiarczuk A, Sharom FJ (2000) Intrinsic fluores-cence of the P-glycoprotein multidrug transporter: Sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry 39:14927-14938
64. Dey S, Ramachandra M, Pastan I, Gottesman MM, Ambud-kar SV (1997) Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc Natl Acad Sci USA 94:10594-10599
65. Shapiro AB, Fox K, Lam P, Ling V (1999) Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. Eur J Biochem 259:841-850
66. Shapiro AB, Ling V (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250:130-137
67. Martin C, Berridge G, Higgins CF, Callaghan R (1997) The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction. Br J Pharmacol 122:765-771
68. Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, Callaghan R (2000) Communication between multiple drug binding sites on P-glycoprotein. Mol Pharmacol 58:624-632
69. Buxbaum E (1999) Co-operative binding sites for transported substrates in the multiple drug resistance transporter Mdr1. Eur J Biochem 265:64-70
70. Loo TW, Clarke DM (2000) The packing of the trans-membrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis. J Biol Chem 275:5253-5256
71. Loo TW, Clarke DM (1994) Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. J Biol Chem 269:7750-7755
72. Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM (1998) Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry 37:13660-13673
73. Currier SJ, Ueda K, Willingham MC, Pastan I, Gottesman MM (1989) Deletion and insertion mutants of the multidrug transporter. J Biol Chem 264:14376-14381
74. Qu Q, Sharom FJ (2001) FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. Biochemistry 40:1413-1422
75. Liu R, Sharom FJ (1997) Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter. Biochemistry 36:2836-2843
76. Liu R, Sharom FJ (1998) Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: A resonance energy transfer study. Biochemistry 37:6503-6512
77. Rosenberg MF, Callaghan R, Ford RC, Higgins CF (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem 272:10685-10694
78. Welker E, Szabo K, Hollo Z, Muller M, Sarkadi B, Varadi A (1995) Drug-stimulated ATPase activity of a deletion mutant of the human multidrug-resistance protein (MDR1). Biochem Biophys Res Commun 216:602-609
79. Kwan T, Gros P (1998) Mutational analysis of the P-glyco-protein first intracellular loop and flanking transmembrane domains. Biochemistry 37:3337-3350
80. Loo TW, Clarke DM (1994) Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. J Biol Chem 269:7243-7248
81. Currier SJ, Kane SE, Willingham MC, Cardarelli CO, Pastan I, Gottesman MM (1992) Identification of residues in the first cytoplasmic loop of P-Glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J Biol Chem 267:25153-25159
82. Choi K, Chen C-J, Kriegler M, Roninson IB (1989) An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glyco-protein) gene. Cell 53:519-529
83. 185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 162:224-231
84. Safa AR, Stern RK, Choi K, Agresti M, Tamai I, Mehta ND, Roninson IB (1990) Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly to Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87:7225-7229
85. Loo TW, Clarke DM (1993) Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. J Biol Chem 268:3143-3149
86. Shoshani T, Zhang S, Dey S, Pastan I, Gottesman MM (1998) Analysis of random recombination between human MDR1 and mouse mdr1a cDNA in a pHaMDR-DHFR bicistronic expression system. Mol Pharmacol 54:623-630
87. Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Du-montet C, Sikic BI (1997) Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem 272:5974-5982
88. Loo TW, Clarke DM (1994) Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33:14049-14057
89. Devine SE, Ling V, Melera PW (1992) Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. Proc Natl Acad Sci USA 89:4564-4568
90. Ma JF, Grant G, Melera PW (1997) Mutations in the sixth transmembrane domain of P-glycoprotein that alter the pattern of cross-resistance also alter sensitivity to cyclosporin A reversal. Mol Pharmacol 51:922-930
91. Hoof T, Demmer A, Hadam MR, Riordan JR, Tummler B (1994) Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glyco-protein MDR1. J Biol Chem 269:20575-20583
92. Beaudet L, Gros P (1995) Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins. Modulation of drug resistance profiles. J Biol Chem 270:17159-17170
93. Hanna M, Brault M, Kwan T, Kast C, Gros P (1996) Mutagene-sis of transmembrane domain 11 of P-glycoprotein by alanine scanning. Biochemistry 35:3625-3635
94. Gros P, Dhir R, Croop J, Talbot F (1991) A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc Natl Acad Sci USA 88:7289-7293
95. Kajiji S, Talbot F, Grizzuti K, Van Dyke-Phillips V, Agresti M, Safa AR, Gros P (1993) Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry 32:4185-4194
96. Hafkemeyer P, Dey S, Ambudkar SV, Hrycyna CA, Pastan I, Gottesman MM (1998) Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Biochemistry 37:16400-16409
97. Gottesman MM (1988) Multidrug resistance during chemical carcinogenesis: A mechanism revealed? J Natl Cancer Inst 80:1352-1353